MMRGlobal CEO Featured in Newsmax as Retrial to Free Dr. Afridi Is Scheduled to Continue Today

MMRGlobal CEO Featured in Newsmax as Retrial to Free Dr. Afridi Is Scheduled to Continue Today

LOS ANGELES, CA — (Marketwired) — 10/08/13 — (OTCQB: MMRF) today called attention to a Newsmax article entitled "-American Hero- Languishes in Jail," profiling in part the humanitarian and philanthropic efforts of MMRGlobal CEO Robert H. "Bob" Lorsch and Company spokesperson Kira Reed Lorsch to free Dr. Shakil Afridi, the man who confirmed the location of Osama bin Laden for the U.S. only to be left behind to serve a 33-year sentence in a remote Pakistani prison cell. Wr

MMRGlobal Receives Additional Biotech Patent Protection in U.S., Mexico and Japan for Cancer Vaccines

MMRGlobal Receives Additional Biotech Patent Protection in U.S., Mexico and Japan for Cancer Vaccines

LOS ANGELES, CA — (Marketwired) — 10/02/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that two additional patents will be granted for its B-cell vaccine technologies. MMR has been notified it will receive another U.S. patent protecting methods of making compositions for B-cell vaccines pursuant to a Notice of Allowance from the United States Patent and Trademark Office. The

MMRGlobal Adds Japan & South Korea to China in Filing of Cancer Fighting Patent Under Expedited Patent Allowance Program

MMRGlobal Adds Japan & South Korea to China in Filing of Cancer Fighting Patent Under Expedited Patent Allowance Program

LOS ANGELES, CA — (Marketwired) — 08/26/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that as a result of the Expedited Patent Allowance Program referred to as the Patent Prosecution Highway ("PPH"), and following the issuance of U.S. patents to MMR for its anti-CD20 monoclonal antibodies, the Company has received confirmation of the filings of a divisional applic

MMRGlobal Files Additional Cancer Fighting Patent in China Under Expedited Patent Allowance Program

MMRGlobal Files Additional Cancer Fighting Patent in China Under Expedited Patent Allowance Program

LOS ANGELES, CA — (Marketwired) — 08/19/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that as a result of China-s participation in the Patent Prosecution Highway Program and the issuance of patents to MMR for its anti-CD20 monoclonal antibodies in the U.S., the Company has received confirmation from China of the filing on August 15, 2013 of a divisional Chinese patent appli

MMRGlobal Announces 51% Overall Increase in 2nd Quarter Revenues Led by MMRPro & Subscriber Revenues

MMRGlobal Announces 51% Overall Increase in 2nd Quarter Revenues Led by MMRPro & Subscriber Revenues

LOS ANGELES, CA — (Marketwired) — 08/15/13 — (OTCQB: MMRF) ("MMR" or the "Company"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that it has filed its quarterly report on Form 10-Q for the second quarter ended June 30, 2013 with the United States Securities and Exchange Commission. Revenues for the quarter increased by 51.2% over the same period in 2012, not including deferred revenue. Und

MMRGlobal to Include Mobile, Telemedicine and Device Monitoring IP Overview in 2nd Quarter Earnings Report

MMRGlobal to Include Mobile, Telemedicine and Device Monitoring IP Overview in 2nd Quarter Earnings Report

LOS ANGELES, CA — (Marketwired) — 08/12/13 — . (OTCQB: MMRF) ("MMR" or the "Company") today announced it plans to file its quarterly report on Form 10-Q for the period ended June 30, 2013 on Wednesday, August 14, 2013. The Company is a leading provider of consumer-controlled (PHRs), storage solutions and electronic document management and imaging systems for , as well as a licensor of its health information technology patents domestically and internationally. Through it

MMRGlobal Announces Investor Q&A Conference Call Following the Company-s Annual Meeting

MMRGlobal Announces Investor Q&A Conference Call Following the Company-s Annual Meeting

LOS ANGELES, CA — (Marketwired) — 07/10/13 — (OTCQB: MMRF) (the "Company") today announced that following its Annual Meeting of Stockholders scheduled for Wednesday, July 17, 2013, the Company will hold an hour-long Q&A Conference Call, on topics unrelated to the Annual Meeting, hosted by Chief Executive Officer Robert H. Lorsch and Chief Financial Officer Ingrid Safranek for investors. The call will start at 1:15 PM Pacific Time / 4:15PM Eastern Time. The Annual Meeting will

MyMedicalRecords Enters Into Agreement With WebMD and Initiates Service Against Jardogs LLC, a Subsidiary of Allscripts

MyMedicalRecords Enters Into Agreement With WebMD and Initiates Service Against Jardogs LLC, a Subsidiary of Allscripts

LOS ANGELES, CA — (Marketwired) — 06/07/13 — . (OTCQB: MMRF) ("MMR") has announced that as previously disclosed, MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal, sued WebMD Health Corp. and WebMD Health Services Group, Inc. (collectively, "WebMD") in federal district court for patent infringement. MMR has entered into a written agreement with WebMD to dismiss the case without prejudice to re-filing the same case again, in order to continue to try and resolv

Dr. Ivor Royston, Oncologist, Scientist, Entrepreneur-Financier and Founding Father of San Diego Biotech, Joins MMRGlobal Board

Dr. Ivor Royston, Oncologist, Scientist, Entrepreneur-Financier and Founding Father of San Diego Biotech, Joins MMRGlobal Board

LOS ANGELES, CA — (Marketwired) — 05/28/13 — (OTCQB: MMRF) ("MMR" or the "Company") today announced that Ivor Royston, M.D. has agreed to join the Company-s Board of Directors effective immediately. MMR-s Board of Directors voted unanimously to authorize management of the Company to extend an invitation to Dr. Royston to serve on the Board. MMR-s management and the Board believe it is in the best interest of the Company and its stockholders to have a director whose exper

MyMedicalRecords Files Patent Infringement Complaint Against Jardogs, a Subsidiary of Allscripts

MyMedicalRecords Files Patent Infringement Complaint Against Jardogs, a Subsidiary of Allscripts

LOS ANGELES, CA — (Marketwired) — 05/20/13 — MyMedicalRecords, Inc. ("MMR"), a wholly owned subsidiary of (OTCQB: MMRF), today announced the filing of a complaint for patent infringement against Jardogs LLC, a subsidiary of Allscripts. The complaint states that Jardogs provides health information services to consumers and healthcare providers and is infringing on MMR-s Personal Health Records patents including U.S. Patent No. 8,301,466. According to the complaint, Jardogs provides